Trial Profile
Observational Prospective Study on Chemoembolization Using Doxorubicin Drug-eluting Bead in Patients With Unresectable Hepatocellular Carcinoma
Status:
Not stated
Phase of Trial:
Phase IV
Latest Information Update: 07 Dec 2021
Price :
$35
*
At a glance
- Drugs Doxorubicin/ethiodized oil (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- Acronyms DEBDOX
- 26 Feb 2019 Planned End Date changed from 1 Dec 2017 to 1 Dec 2021.
- 26 Feb 2019 Planned primary completion date changed from 1 Sep 2017 to 1 Sep 2021.
- 02 Aug 2016 Planned number of patients changed from 40 to 100.